Abstract
INTRODUCTION
The widespread use of imaging as a screening modality for various diagnostic and health check ups has led to a rapid increase in the frequency of detection of small, lowgrade and early renal tumours; with a vast majority (threefourth) of them being less than 4 cms in size (T 1a ). [1] The primary goals of management of such renal neoplasm(s) include, maximising local cancer control (by minimising margin positivity and cancer recurrence), preserving renal function (by minimising the warm ischemia time) and minimising patient morbidity/hospital stay (through better haemostasis and lower robotic/console operating times). The current management options include nephron sparing surgery or partial nephrectomy through open or minimally invasive surgery (laparoscopic or robot-assisted laparoscopic ablation, cryoablation, radiofrequency ablation). We review the technique and currently published select series on robot-assisted laparoscopic partial nephrectomy (RPN) that have been reported in English literature to date.
Robot-assisted transperitonal technique of partial nephrectomy (i) Patient positioning, port placement and docking:
The procedure is initiated with the patient in the supine position, under general endotracheal anaesthesia. The patient is placed in the modified flank position with an axillary and kidney roll, leg padding/pillows and a padded arm holder for the ipsilateral upper extremity. A high flow, low pressure pneumoperitoneum is obtained with a Veress needle. An incision is made superolateral to the umbilicus (pararectal) for the 12 mm camera port. Under laparoscopic visualization, two 8 mm robotic ports are placed superior and inferior to the camera port. Additional 12 and 5 mm port(s) can be placed below the two 8 mm robotic ports in the midline, superior and inferior to the umbilicus. The optional third 8 mm robotic port for the third robotic arm can be placed about three fingers above the ipsilateral anterior superior iliac spine 5 cm away from the inferior 8 mm robotic port. The robot cart is aligned and docked at an angle from behind the patient. The typical port site placement for left robot-assisted partial nephrectomy is illustrated in a diagrammatical sketch [ Figure 1 The renal tumour is excised en-bloc with the overlying perinephric fat. In case of any doubt of whether the renal pelvicalyceal system has been entered, one can administer intravenous indigo carmine to visualise any gross leaks, in case these are apparent they can be repaired with a 7-8 inches long running suture of 3-0 vicryl (TM) on an RB-1 needle placed with the aid of the robotic needle driver and held in place with lapra-Ty (TM) clips. The renal defect can then be buttressed with a Surgicel™ bolster (only for wide defects exceeding 3-4 cm) and oversewn with 1-2 previously prepared 1-0 Monocryl™ sutures with a knot, and a preplaced LapraTy TM and a Weck Hem-o-Lock TM clip, proximal to its knotted end. Additional Hem-o-Lock TM clips can be placed by an assistant after centering the suture on the jaws of the clip, after each completed throw of the suture(s) which can be clipped and tightened (held with a ProGrasp TM forceps and slid down the renal capsule with a robotic needle driver). In case of persistent bleeding, an additional layer of Surgicel™ with 5 cc of FloSeal TM (Baxter Healthcare Corp, Fremont, CA, USA) can be applied to the renal defect. The laparoscopic bulldog clip remover is introduced via the 12 mm assistant port and the renal vessels are unclamped and the end of the warm ischemia time (WIT) is noted. The vascular slings are cut and removed along with the clip. After assuring haemostasis another injection of IV 12.5 gm Mannitol is administered. The perirenal fat is loosely re-approximated with a 3-0 Monocryl TM suture and the excised specimen is retrieved with an endoscopic bag. The robotic instruments are removed and the robot is undocked. (iii) Closure: A flank drain is generally placed in the renal bed and all the ports are removed under vision. The camera port is extended by about 1 cm to facilitate retrieval of the endoscopic bag. All port sites are closed at the fascia level with a Vicryl TM suture. The skin can be re-approximated with a sub-cuticular 4-0 Monocryl TM suture.
Review of literature
Open partial nephrectomy has been the gold standard for Ͻ4 cm renal neoplasm(s), with the reported cure rates approaching close to those achieved with open radical nephrectomy. [2, 3] The goal of RPN is to duplicate the oncological and functional outcome of open radical nephrectomy. The first laparoscopic partial nephrectomy (LPN) was performed through transperitoneal access and retroperitoneal access, by Winfield [4] and Gill et al., [5] respectively. Robotic technique of partial nephrectomy was apparently initially performed and subsequently published by Gettman and colleagues in 2004. [6] With the emergence of the surgical daVinci (TM) robotic system, increasingly more workers [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] have also reported and described the technique of transperitoneal RPN [ Table 1 ]. To date, the two largest series of RPN reported are by Rogers [13] and Wang et al., [7] [ Table 1 ]. Table 1 Shows a comparative review of the salient features of select series on robotic partial nephrectomy, as reported and published in the indexed English literature.
(a) Tumour Characteristics: The mean reported renal tumour size treated by RPN has been (2-3.1) cm [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] with the largest being 6.4 cm in size. [13] The use of intraoperative laparoscopic ultrasound and colour Doppler is useful for precise location, delineation of an endophytic tumour and for identifying the [10] Recently some have also used the TilePro (TM) (projection of preoperative CT images and live intraoperative ultrasound imaging directly on to the surgical console) feature of the daVinci-S (TM) robotic system to facilitate renal tumour localisation and resection. [21] In our opinion, for select endophytic or larger renal tumours in an otherwise inaccessible location, the use of an integrated, intraoperative, laparoscopic, ultrasound probe device like the TilePro (TM) can facilitate RPN. With the addition of the fourth arm for the robot it is apparent that this will provide the console surgeon a greater degree of precision in facilitating renal hilar dissection and vascular control.
(b) Hilar Control and Bleeding:
The challenging steps in RPN that require significant expertise and learning are hilar dissection/control and renorraphy. Hilar dissection/ control is more daunting, as improper clamping due to overlooked accessory renal vessels can cause significant bleeding. This can be prevented by looking for immediate blanching of the kidney after clamping the renal hilar vessels, failure of the kidney to blanch should prompt the surgeon to release the clamps and dissect more proximally to reapply the laparoscopic bulldog clips. The presence of multiple renal vessels in about 20% of the cases is an important consideration (preoperative CT/MR angiography is an essential tool to evaluate them). Options include (i) enbloc clamping of all the renal vessels with a single Satinsky clamp or (ii) individual accessory vessel skeletonization and secure clamping with laparoscopic bulldog clips. Other workers have also demonstrated the feasibility of RPN in complex renal hilar tumors. [12] (c) Haemostatic Agents: Floseal TM is a synthetic thrombin-based gelatine matrix tissue hemosealant activated upon contact with blood, deliverable laparoscopically. [22] Risks of using Floseal TM include transmission of bovine spongiform encephalopathy/hepatitis (bovine source of collagen), but contact with urine hinders its action. [23] To alleviate the high cost of Floseal TM one may use the more economical purified potato starch powder (Arista TM ), which may turn out to be a promising substitute for haemostasis. Purified potato starch powder (PPSP) is composed of bio-polymeric, micro-porous polysaccharide hemospheres (MPH ® ) that acts as sieves, dehydrating the blood and accelerating the process of clotting. PPSP can be easily delivered through a 5 mm assistant laparoscopic port, using a distally fenestrated flexi tip applicator attached to a plastic billows container, it is also hypoallergenic and carries no risk of disease transmission. [24] TM (oxidised wood pulp cellulose, Ethicon Inc., Somerville, NJ) bolster has been generally used to buttress renal defects following RPN, which acts by virtue of its cellulosic acid, producing an artificial clot due to its affinity for haemoglobin. It is a non-toxic, biocompatible, bio-soluble, bio-degradable anti-oxidant, with bactericidal and wound healing properties. [23] In our opinion and also of the others, [25] the use of Surgicel TM should be restricted to select small renal neoplasm(s), not easily amenable to a direct closure. Recently Weight and co-workers [26] described an alternative technique of no-bolstered renorraphy in LPN for centrally located tumours, to reduce their WIT. Experimental data has shown that the use of cold ischemia may be more advantageous for prolonged renal ischemia, and renal hypothermia may be associated with better haemostasis and renal function. [27] (d) Outcome Parameters: In the present series of published cases reviewed in Table 1 the mean ORT (CT) and hospital stay was 191.27 minutes and 2.95 days, respectively, in the global select RPN series [ Table 1 ]. The computed average of WIT and estimated blood loss (EBL) has been 25.37 and 170 ml, respectively, in the global select RPN series [ Table 1 ]. (e) ORT and BMI: Morbid obesity (body mass index greater than 30 kg/ m 2 ) may impact the results of RPN, especially in terms of the operating/console time and blood loss. Published data proves that morbid obesity may be related to a higher risk of renal cell carcinoma (RCC) and their surgical management may be associated with higher or similar complication rates. [28, 29] In our opinion obesity may no longer be viewed as a contraindication to RPN. (f) WIT and Renal function: In our opinion certain measures can be adopted in select cases to further reduce the WIT, and/or maximise the renal function including: (i) no bolster renorraphy for select centrally located renal tumours, (ii) bolstered renorraphy for polar tumours with suturing of the collecting system, (iii) routine use of the sliding clip renorraphy technique, (iv) maximising the use of TilePro TM and the fourth arm of the robot during an RPN and (v) considering the use of cold ischemia in place of warm ischemia. Mean WIT has been 25.37 minutes in the global RPN series [ Table 1 ]. Others have reported a 'U' looped vascular sling passed around the renal vessels, threaded over a tube, at its ends (that functions as a tourniquet), to enable a transient vascular occlusion in the RPN, as an alternative to the LBD/Satinsky TM clamp. [30] Some workers have used the fourth arm of the robot with its long tip forceps to occlude the renal artery during resection of the renal mass in an RPN. [31] However it remains to be proven whether this actually has the potential to lower WIT and improve renal function. (g) Complications: Review of a select series reveals an overall 7.4% complication rate associated with RPN, most of which appears to be minor in nature. Minor: Lee et al., [17] reported port site infection in 1/9 patients. Michli et al., [20] reported the detection of renal abscess in 1/20 of their patients. Getman et al., [6] reported prolonged ileus in 1/13 of their patients following RPN. Urinary leak following RPN was reported by Roger et al. [12, 13] and Kaul et al., [11] in 2/11-2/148, and 1/10 of their patients respectively. Lee et al., [17] also reported the occurrence of a urinoma in 1/9 of their patients. Major: Michli [20] and Caruso et al., [14] reported a conversion to open/hand-assisted laparoscopic partial nephrectomy in 3/20 and 2/10 patients undergoing a planned RPN procedure. Excessive troublesome bleeding associated with RPN was reported by Dean et al., [8] Rogers et al., [13] and Kaul et al., [11] in 1/10, 1/148, and 1/9 of their patients, respectively. Wang et al., [7] Philisp et al. [15] and Getman et al., [6] also reported a positive tumour margin (PSM) in 1/40, 2/12 and 2/13 patients undergoing RPN, respectively. Michli et al. [20] and Gettman et al., [6] also reported the occurrence of pulmonary embolism in 1/20 and 2/144 of their patients undergoing RPN.
According to a certain comparative series [32, 33] the mean ORT, EBL and WIT may be significantly lower with RPN versus LPN, however, individual results tend to vary. Larger prospective randomised controlled trials between the two are the need of the day in order to properly address this issue. Cost factor may serve as a drawback to the universal acceptance of RPN for T1 renal tumours; while no cost comparisons have been reported in the literature when comparing the cost of RPN versus LPN, it likely that due to the high recurring cost of the da-Vinci (TM) surgical robotic system, the former would be more expensive. [34] RPN is overall a complex surgical procedure that should be undertaken by urologists familiar with the technique of open and/or laparoscopic partial nephrectomy and who are well-conversant with the technicalities of robotic console surgery. Excellent coordination between the robotic console surgeon, assistant surgeon and other team members is of paramount importance in order to achieve a consistently favourable outcome.
CONCLUSIONS
In our opinion robot-assisted laparoscopic partial nephrectomy is a therapeutically adequate, minimally invasive, surgical modality of choice for most cases of incidental and early renal neoplasm(s) of T 1 stage. More than 350 cases of RPN have been currently performed worldwide; it is currently the most minimally invasive alternative surgical modality of choice to open/ laparoscopic partial nephrectomy that best mimics the oncological principles of surgery. With adequate experience, select multiple, complex, hilar and peri-hilar renal lesions too can be treated successfully with RPN. Morbid obesity may not be associated with a longer operating time. The drawbacks of some of the currently published studies reviewed in this manuscript include lack of renal scans, analgesic requirements and pain scores; these were not considered, as also long-term data are still awaited. Few studies have evaluated a comparative assessment of RPN with LPN.
